1. What Is the Point of Care Chemistry Market?
The Point of Care Chemistry Market covers portable analysers and test systems measuring metabolic, electrolyte, cardiac, and haematological chemistry panels at the patient bedside, clinic, or non-laboratory setting. POC chemistry encompasses blood gas and critical care analysers, urinalysis dipstick and microalbumin, handheld glucose and HbA1c, and portable chemistry panel analysers. Market dynamics reflect ED and ICU workflow efficiency driving POC critical care adoption, diabetic monitoring expanding POC glucose demand, and POC HbA1c enabling diabetes management without laboratory send-out.
2. Point of Care Chemistry Market Size & Forecast
3. Emerging Technologies
- Miniaturised POC chemistry panels testing comprehensive metabolic panel results from a fingerstick drop of blood are advancing as access tools. Growing adoption at primary care clinics is driven by send-out laboratory avoidance requirements.
- POC HbA1c enabling diabetes glycaemic control monitoring without venipuncture are advancing as patient convenience tools. Growing adoption at endocrinology and primary care is driven by patient adherence to diabetes monitoring requirements.
- Continuous lactate monitoring in ICU patients enabling real-time sepsis shock resuscitation guidance are advancing. Growing adoption at critical care is driven by sepsis treatment titration requirements.
- Point-of-care urinalysis systems enabling immediate dipstick and microscopy results at clinic without laboratory submission are advancing. Growing adoption at urgent care and primary care is driven by same-visit UTI diagnosis requirements.
Such innovations are driving change across adjacent industries too. Discover more in our Coagulation Poc Market.
4. Key Market Opportunity
The leading opportunity in the Point of Care Chemistry Market is the critical care POC blood gas and electrolyte sub-market, where ED and ICU workflow integration creates high-volume cartridge-based recurring revenue. Diabetic POC HbA1c creates a large ambulatory care revenue channel as diabetes management monitoring shifts from laboratory to clinic or home. Cardiac POC troponin creates a premium ED revenue opportunity as high-sensitivity troponin POC enables 1-hour AMI rule-out. Asia Pacific POC chemistry creates geographic expansion as Chinese, Indian, and Southeast Asian urgent care and primary care POC adoption grows.
5. Top Companies in the Point of Care Chemistry Market
The following organisations hold leading positions in the Point of Care Chemistry Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott (i-STAT Alinity)
- Roche (cobas b 123)
- Siemens Healthineers (epoc)
- Radiometer (AQT90)
- Nova Biomedical
- Beckman Coulter (iQM)
- Instrumentation Laboratory
- Werfen
- Quidel (Sofia POC)
- bioMerieux
6. Market Segmentation
The Point of Care Chemistry Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Parameter | Blood Gas and Electrolytes Glucose and HbA1c Cardiac Troponin POC Urinalysis Panel Chemistry |
| By Setting | ED and ICU Bedside Primary Care Clinic Home Monitoring Ambulance EMS |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Chemistry Market trajectory over the forecast period:
Abbott i-STAT Alinity Achieves 500,000 Annual Cartridge-Based POC Chemistry Tests in Critical Care.Abbott i-STAT Alinity achieving 500,000 annual cartridge-based POC test runs in US hospital EDs and ICUs in 2024 demonstrates POC chemistry scale in acute care. The i-STAT achieving 10-minute turnaround for blood gas, electrolyte, and troponin panel demonstrates the time-to-result advantage driving ED and ICU POC chemistry adoption.
Roche cobas b 123 Blood Gas Analyser Achieves 90 Percent US ICU POC Blood Gas Market Share.Roche cobas b 123 blood gas POC system achieving 90 percent US ICU blood gas analyser market share by installed base in 2024 demonstrates blood gas POC market concentration. Roche cobas b 123 achieving 5-minute blood gas result turnaround versus 30-minute central lab result demonstrates the critical care clinical workflow rationale for POC blood gas adoption.
Siemens epoc POC Analyser Achieves ED Wireless Integration With Electronic Medical Records.Siemens Healthineers epoc achieving wireless EMR integration with Epic and Cerner in 400 US EDs in 2024 demonstrates POC chemistry EMR connectivity standard. The epoc wireless result transmission achieving 15-minute reduction in physician time-to-result versus manual data entry demonstrates the workflow value of POC-EMR connectivity.
For related market intelligence, see the Immunoassay Market.
8. Segmental Analysis
By parameter, the Blood Gas and Critical Care Panel segment dominated the Point of Care Chemistry Market in 2025. Representing the largest revenue category as ED and ICU bedside testing drives continuous cartridge consumption. The POC HbA1c and Glucose Management segment is the fastest-growing category, advancing as diabetes management guideline emphasis on glycaemic control drives ambulatory POC monitoring.
By setting, the ED and ICU segment dominated the Point of Care Chemistry Market in 2025. Representing the largest setting revenue share. The Primary Care Clinic segment is the fastest-growing setting category, advancing as clinical protocol standardisation and reimbursement expansion broaden market access. The ED and ICU structural position and Primary Care Clinic growth momentum establish the core setting segmentation dynamic for the Point of Care Chemistry Market through 2034.
9. Regional Analysis
Regional demand patterns across the Point of Care Chemistry Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Point of Care Chemistry Market in 2025, holding 46.2% of the global market. Emergency physicians, intensivists, and critical care programmes are deploying point-of-care chemistry testing systems to enable rapid bedside measurement of critical analytes including blood gases, electrolytes, glucose, and lactate for immediate clinical decision-making. FDA waived and moderately complex POC chemistry device clearances and CMS reimbursement for emergency and critical care testing are encouraging clinical programmes to invest in decentralised chemistry testing infrastructure. High emergency department visit volumes, established critical care infrastructure, and strong demand for rapid diagnostic results are generating regional demand.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 13.27% during the forecast period. Emergency departments, intensive care units, and point-of-care testing networks across China, India, Japan, and Southeast Asia are deploying chemistry POC systems to deliver rapid diagnostic results in high-volume, time-critical clinical settings. Government investment in emergency care infrastructure and increasing adoption of decentralised testing in hospitals lacking comprehensive central laboratory capacity are driving POC chemistry adoption. Rising emergency department volumes and growing demand for rapid metabolic and blood gas testing in intensive care settings are generating demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Chemistry Market was valued at USD 4.44 Bn in 2025 and is projected to reach USD 11.09 Bn by 2034, growing at a CAGR of 10.7% over the 2026–2034 forecast period.
The Point of Care Chemistry Market is projected to grow at a CAGR of 10.7% from 2026 to 2034.
North America accounted for the largest share of the Point of Care Chemistry Market in 2025, holding 46.2% of the global market.
The leading companies in the Point of Care Chemistry Market include Abbott (i-STAT Alinity), Roche (cobas b 123), Siemens Healthineers (epoc), Radiometer (AQT90), Nova Biomedical, Beckman Coulter (iQM), Instrumentation Laboratory, Werfen, Quidel (Sofia POC), bioMerieux.
Abbott i-stat alinity achieves 500,000 annual cartridge-based poc chemistry tests in critical care.
By parameter, the Blood Gas and Critical Care Panel segment dominated the Point of Care Chemistry Market in 2025.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 2 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 2 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 2 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.